<i>BRAF</i> V600E Is a Determinant of Sensitivity to Proteasome Inhibitors
Davide Zecchin(The Francis Crick Institute), Federica Di Nicolantonio(IFOM)
Cited by 20
Related Papers
GNAQ/GNA11 Mosaicism Causes Aberrant Calcium Signaling Susceptible to Targeted Therapeutics
|Journal of Investigative Dermatology|2023|21